Author

N. Demircan

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Capecitabine-induced pneumonitis: a rare case report and literature review.

Capecitabine is an oral fluoropyrimidine prodrug widely used in the treatment of various malignancies, including colorectal cancer. While it is generally well-tolerated, rare and life-threatening toxicities can occur. Pneumonitis is an exceedingly rare complication associated with capecitabine monotherapy. A 36-year-ol...

M. A. Tunç, A. Güren, B. Paçacı et al. · Anti-Cancer Drugs · 0 citations

Review Open access Sep 2026

Baseline and Early On-Treatment Prognostic Nutritional Index in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer Treated with CDK4/6 Inhibitors

Background/Objectives: The prognostic nutritional index (PNI) has been associated with outcome in metastatic breast cancer, but studies in CDK4/6 inhibitor-treated patients have used cohort-derived thresholds and examined only the pretreatment value. We assessed the PNI as a continuous variable, compared it with inflam...

E. Çoban, A. Kurt, Fırat Akagündüz et al. · Journal of Clinical Medicine · 0 citations

Open access 2026

Prognostic Factors in Advanced Bladder Cancer: A Real-World Retrospective Analysis

Introduction: Metastatic bladder cancer (mBC) is associated with poor outcomes. Despite advances in immunotherapy and targeted agents, platinum-based chemotherapy remains a cornerstone of treatment in real-world practice. We aimed to identify pragmatic and readily available prognostic factors for risk stratification in...

Zeynep Alaca Topçu, M. Ozturk, M. Yıldırım et al. · Haydarpasa Numune Training a... · 0 citations